Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Ludwig

Showing results (181-190 of 231) with videos related to

Pageof 24
Sort By:
Antiviral Research|July 2, 2013
The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic avian influenza A virusEmanuel Haasbach, Sarah Julia Reiling, Christina Ehrhardt, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
<i>Hypericum perforatum</i> and Its Ingredients Hypericin and Pseudohypericin Demonstrate an Antiviral Activity against SARS-CoV-2Fakry F Mohamed, Darisuren Anhlan, Michael Schöfbänker, et al.
Frontiers in Immunology|October 17, 2018
Phosphorylation of TRIM28 Enhances the Expression of IFN-β and Proinflammatory Cytokines During HPAIV Infection of Human Lung Epithelial CellsTim Krischuns, Franziska Günl, Lea Henschel, et al.
Immunology|April 20, 2011
Role of proteinase-activated receptor-2 in anti-bacterial and immunomodulatory effects of interferon-γ on human neutrophils and monocytesVictoria M Shpacovitch, Micha Feld, Dirk Holzinger, et al.
Emerging Microbes & Infections|September 9, 2024
Molecular characterisation of influenza B virus from the 2017/18 season in primary models of the human lung reveals improved adaptation to the lower respiratory tractDuygu Merve Çalışkan, Sriram Kumar, Saskia Hinse, et al.
Archives of Public Health = Archives Belges De Sante Publique|August 17, 2021
Citizens, doctors, politicians - who´s an expert in times of COVID-19? A survey in Austria and GermanyDagmar Schaffler-Schaden, Juergen Herfert, James O Brien, et al.
Plos One|May 16, 2020
The influenza replication blocking inhibitor LASAG does not sensitize human epithelial cells for bacterial infectionsJanine J Wilden, Andre van Krüchten, Lutz Gieselmann, et al.
Biomolecules|June 2, 2021
Inhibition of Phosphatidylinositol 3-Kinase by Pictilisib Blocks Influenza Virus Propagation in Cells and in Lungs of Infected MiceStefanie Deinhardt-Emmer, Laura Jäckel, Clio Häring, et al.
Journal of Virology|December 17, 2009
The NS segment of an H5N1 highly pathogenic avian influenza virus (HPAIV) is sufficient to alter replication efficiency, cell tropism, and host range of an H7N1 HPAIVWenjun Ma, Dominique Brenner, Zhongfang Wang, et al.
Nature Medicine|September 4, 2007
Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shockThomas Vogl, Klaus Tenbrock, Stephan Ludwig, et al.
Pageof 24

Showing results (181-190 of 231) with videos related to

Sort By:
Pageof 24
Antiviral Research|July 2, 2013
The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic avian influenza A virusEmanuel Haasbach, Sarah Julia Reiling, Christina Ehrhardt, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
<i>Hypericum perforatum</i> and Its Ingredients Hypericin and Pseudohypericin Demonstrate an Antiviral Activity against SARS-CoV-2Fakry F Mohamed, Darisuren Anhlan, Michael Schöfbänker, et al.
Frontiers in Immunology|October 17, 2018
Phosphorylation of TRIM28 Enhances the Expression of IFN-β and Proinflammatory Cytokines During HPAIV Infection of Human Lung Epithelial CellsTim Krischuns, Franziska Günl, Lea Henschel, et al.
Immunology|April 20, 2011
Role of proteinase-activated receptor-2 in anti-bacterial and immunomodulatory effects of interferon-γ on human neutrophils and monocytesVictoria M Shpacovitch, Micha Feld, Dirk Holzinger, et al.
Emerging Microbes & Infections|September 9, 2024
Molecular characterisation of influenza B virus from the 2017/18 season in primary models of the human lung reveals improved adaptation to the lower respiratory tractDuygu Merve Çalışkan, Sriram Kumar, Saskia Hinse, et al.
Archives of Public Health = Archives Belges De Sante Publique|August 17, 2021
Citizens, doctors, politicians - who´s an expert in times of COVID-19? A survey in Austria and GermanyDagmar Schaffler-Schaden, Juergen Herfert, James O Brien, et al.
Plos One|May 16, 2020
The influenza replication blocking inhibitor LASAG does not sensitize human epithelial cells for bacterial infectionsJanine J Wilden, Andre van Krüchten, Lutz Gieselmann, et al.
Biomolecules|June 2, 2021
Inhibition of Phosphatidylinositol 3-Kinase by Pictilisib Blocks Influenza Virus Propagation in Cells and in Lungs of Infected MiceStefanie Deinhardt-Emmer, Laura Jäckel, Clio Häring, et al.
Journal of Virology|December 17, 2009
The NS segment of an H5N1 highly pathogenic avian influenza virus (HPAIV) is sufficient to alter replication efficiency, cell tropism, and host range of an H7N1 HPAIVWenjun Ma, Dominique Brenner, Zhongfang Wang, et al.
Nature Medicine|September 4, 2007
Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shockThomas Vogl, Klaus Tenbrock, Stephan Ludwig, et al.
Pageof 24